Market Place
Sourcing Support
Drugmaker receives FDA warning letter after hindered inspection
20 Nov 2024 //
FDA
FDA Rejects Astellas’ Effort to Extend Eye Drug Izervay Use
19 Nov 2024 //
ENPTS
Supreme Court Asks Zydus to Approach Delhi HC Over Sigrima Ban
19 Nov 2024 //
ECONOMICTIMES
VBI recalls hepatitis B shot as it winds down operations
18 Nov 2024 //
FIERCE PHARMA
Endo Expands Voluntary Recall of Clonazepam Due to Mislabeling
18 Nov 2024 //
PR NEWSWIRE
Dr Reddy`s, FDC recall products in US for manufacturing issues
17 Nov 2024 //
ECONOMICTIMES
GAO takes FDA to task over lagging drug plant inspections
14 Nov 2024 //
FIERCE PHARMA
FDA slams Merz over `misleading` Instagram ad for Botox rival
14 Nov 2024 //
FIERCE PHARMA
Supreme Court Rejects Plea to Mandate Doctor on Drug Side-Effects
14 Nov 2024 //
FINANCIALXPRESS
Cipla gets 8 observations after FDA inspection at Bengaluru plant
13 Nov 2024 //
CNBCTV
PharmaTher Granted FDA Clarification for Ketamine NDA
13 Nov 2024 //
GLOBENEWSWIRE
China-Based Chemical Company Indicted for Alleged Fentanyl Manufacturi
12 Nov 2024 //
FDA
Buxton Releases Evidence of Product-Related Fraud at Assertio
11 Nov 2024 //
BUSINESSWIRE
CDSCO May Regulate Health Supplements to Stem Unapproved Claims
05 Nov 2024 //
ECONOMICTIMES
Dr. Reddy’s recalls thyroid drug over carcinogen concerns
04 Nov 2024 //
FIERCE PHARMA
Shilpa Medicare Falls After FDA Issues 4 Observations at Facility
31 Oct 2024 //
BUSINESS STD
Novo Nordisk Faces FDA Write-Up Over Semaglutide Plant Issues
31 Oct 2024 //
FIERCE PHARMA
Biocon Biologics` Bengaluru Unit Receives Voluntary FDA Action
30 Oct 2024 //
ECONOMICTIMES
Exactech Files for Bankruptcy After Recall Litigation
30 Oct 2024 //
REUTERS
High Court reinstates Injunction stopping sale of Zydus’ Sigrima
29 Oct 2024 //
EXPRESSPHARMA
Sai Life Sciences Receives EIRs from USFDA for R&D Facilities
28 Oct 2024 //
GLOBENEWSWIRE
CDSCO flags 49 medicine for failing quality; 4 declare as spurious
26 Oct 2024 //
ECONOMICTIMES
BeiGene, ex-AstraZeneca exec faces investigation in China: reports
25 Oct 2024 //
FIERCE PHARMA
Delhi HC Refuses Abbott`s Appeal in Mebufen Trademark Dispute
25 Oct 2024 //
PHARMABIZ
Dentsply Sirona voluntarily suspends sales of its teeth aligners
24 Oct 2024 //
REUTERS
DoP Rejects Review Applications on Metoprolol Pricing
24 Oct 2024 //
PHARMABIZ
Compassion Center Calls for Misleading Psychedelic Products
24 Oct 2024 //
ACCESSWIRE
$76 Million In Illegal E-Cigarettes Seized In Operation
22 Oct 2024 //
PR NEWSWIRE
FDA Recalls Thousands Of Duloxetine Antidepressant Bottles
22 Oct 2024 //
TIMESNOWNEWS
Irhythm Secures 510(K) Clearance For Zio Device Updates
21 Oct 2024 //
YAHOOFINANCE
Humacyte issues raised in 483 appear ‘fixable,’ says BTIG
18 Oct 2024 //
TIPRANKS
Listeria, Salmonella Represent 40% Of FDA Food Recalls
17 Oct 2024 //
FOODSAFETY
Indoco Remedies` Goa plant classified as OAI by US FDA
14 Oct 2024 //
BUSINESS STANDARD
FDA found contamination issues at Thermo Fisher NC plant
12 Oct 2024 //
FIERCE PHARMA
U.S. lifts import ban on Malaysian glove maker Brightway
11 Oct 2024 //
REUTERS
More Fixed Dose Combo May Be Banned Due To Lack Of Justification
09 Oct 2024 //
ECONOMICTIMES
Ordered Recall Of Drugs Not Meeting Quality Standards Initiated
09 Oct 2024 //
ECONOMICTIMES
Alembic rises after oncology completes FDA with `zero` observations
09 Oct 2024 //
BUSINESS STD
Medtronic recalls MiniMed insulin pumps over drained batteries
08 Oct 2024 //
FIERCE BIOTECH
FDA compliance official highlights priorities onsite inspections
07 Oct 2024 //
RAPS
Medtronic Recalls MiniMed Pumps Due To Battery Life Risk
07 Oct 2024 //
PHARMABIZ
Lupin`s Pune-based biotech facility gets 5 observations from US FDA
05 Oct 2024 //
BUSINESS STD
Govt may mandate QR codes to check fake cancer drugs
05 Oct 2024 //
ECONOMICTIMES
FDA boosts Philips recall of hospital, home ventilator software
02 Oct 2024 //
FIERCE BIOTECH
Kezar Reports Four Patient Deaths in Mid-Stage Lupus Nephritis Study
02 Oct 2024 //
BIOSPACE
USFDA Inspection Update On Jubilant HollisterStier’s Facility
01 Oct 2024 //
INDPHARMAPOST
U.S. FDA issues 10 observations to Aurobindo arm`s API unit
01 Oct 2024 //
THE HINDU
USFDA Completes Inspection At Biocon Biologics’ Insulin Facility
30 Sep 2024 //
INDPHARMAPOST
CDSCO declares 59 drugs tested in August as Not of Standard Quality
28 Sep 2024 //
PHARMABIZ
Alkem Labs denies claims of Pan-D, Clavam 625 batches
27 Sep 2024 //
ECONOMICTIMES
Torrent Pharma Refutes Shelcal 500 Quality Test Claims
27 Sep 2024 //
INDPHARMAPOST
Dr Reddy’s fined by Mexican regulator for compliance violation
26 Sep 2024 //
EXPRESSPHARMA
Gilead recalls 1 lot of Veklury due to glass particle in vial
26 Sep 2024 //
FIERCE PHARMA
Pfizer pulls sickle cell disease drug Oxbryta from global markets
26 Sep 2024 //
PRESS RELEASE
FDA boosts 3 recalls of Smiths Medical ventilators, trach tubes
23 Sep 2024 //
FIERCE BIOTECH
Aarti Drugs Gets Form 483 With 7 USFDA Observations At API Facility
20 Sep 2024 //
EQUITYBULL
Glenmark Shares Surge on Positive FDA Inspection
20 Sep 2024 //
INDIA INFOLINE
Glenmark Pharma Aurangabad unit clears FDA test
20 Sep 2024 //
CNBCTV
Torrent Pharm Receives Form 483 From US FDA After Inspection
20 Sep 2024 //
NDTV
Apellis Receives Negative CHMP Opinion for Pegcetacoplan
20 Sep 2024 //
GLOBENEWSWIRE
